Abstract
Background: About 5% of all breast cancer cases are attributable to germline mutations in BRCA1 or BRCA2 genes. BRCA mutations in suspected carriers, however, may be missed, which hampers genetic...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have